Trusted News Discovery Since 2008
{{/content}}
Dosing Mix-up Raises Questions About New COVID Vaccine
Video Credit: Wochit News
Published on November 26, 2020 - Duration: 00:39s
Dosing Mix-up Raises Questions About New COVID Vaccine
A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed.
The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford.
Less than a week after we learned about it, the developers have admitted to a manufacturing error.
The error resulted from two different doses during the recently concluded phase III trial.
AstraZeneca and the University of Oxford described the vaccine as being 70% effective.
You are here
Related news from verified sources
"These figures ... shows that the vaccine in the right dosage can be up to 90% effective," he told Sky News, after an announcement from AstraZeneca. "We've got...
on November 23, 2020 • IndiaTimes
A second experimental COVID-19 vaccine — this one from Moderna Inc. — yielded extraordinarily strong early results Monday, another badly needed dose of hope...
on November 18, 2020 • Mid-Day
A *Mumbai*-based travel company is offering to fly people, who want to get *COVID-19* vaccine, to the United States for a 4-day stay at a cost of Rs 1.75 lakh....
on November 26, 2020 • Mid-Day
Related videos from verified sources
COVID Vaccines That Require 2 Doses Create New Set Of Challenges 02:27
Video credit: WBZ CBS Boston - Published on November 30, 2020
Moderna Applies For Emergency FDA Authorization After Successful Vaccine Trials 02:17
Video credit: CBS 2 New York - Published on November 30, 2020
Moderna to file for emergency authorization of its Covid-19 vaccine in US and Europe|Oneindia News 02:29
Video credit: Oneindia - Published on November 30, 2020